Dr Topalian speaks with ecancer at AACR 2017 about the combination of ipilimumab and nivolumab for advanced melanoma. The results were presented at the conference by Dr James Larkin, and Dr Topalian comments on the response rates and overall survival in...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nDY5Gg
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου